Last edition
News about "Takeda Pharma"
Takeda invests 300 M to build new production facility for plasma-derived therapies
As part of Takeda’s commitment to have net zero carbon emissions by 2030, the new facility will be self-sufficient in electricity
Takeda Pharma | 14/09/2022 | By Sudeep Soparkar | 500
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members